Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Quantitative 3D Micro-CT Imaging of Human Lung Tissue
Kampschulte, Marian, Litzlbauer, H., Tscholl, Dietmar, Zeiner, Carsten , Krombach, Gabriele A. , Ritman, Erik L., Bohle, Rainer M., Langheinirch, A., Schneider, C. , Langheinirch, A.

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren | July 25, 2013 | Volume: 185 | Issue: 09 | Pages: 869-876

10.1055/s-0033-1350105 | PMID 23888470 Get It

Faculty Opinions recommendation of Autism and mental retardation among offspring born after in vitro fertilization.
Coddington, Charles C.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | July 25, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718025962.793480030 Get It

A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients
Reid, Gail , Huprikar, Shirish , Patel, Gopi , Mossad, Sherif B. , Levi, Marilyn E. , Gregg, Kevin , Humar, Atul , Adams, William , Kumar, Deepali , Razonable, Raymund R. , Shoham, Shmuel

Transplant Infectious Disease | July 25, 2013 | Volume: 15 | Issue: 5 | Pages: 487-492

10.1111/tid.12116 | PMID 23890293 Get It

AbstractBackgroundHematopoietic stem cell transplant (HSCT) recipients have increased morbidity from respiratory viral infections. Pandemic influenza A – A(H1N1)/pdm09 – in 2009–2010 was associated with increased severity of illness in patients with underlying co‐morbidities including HSCT, but the factors that contribute to severe disease in HSCT patients are not well characterized.MethodsWe conducted a multicenter review of microbiologically proven influenza A(H1N1)pdm09 in the HSCT population between April 2009 and April 2010 to determine factors that are associated with severe disease.ResultsWe identified 37 adult patients (26 allogeneic and 11 autologous HSCT recipients). Median time from transplant to diagnosis was 411 days (range 4 days–14.9 years). Three cases were hospital acquired. Twenty‐eight of 37 (75.7%) had confirmed A(H1N1)pdm09. Presumed viral lower respiratory tract infection was present in 12/37 (32.4%) patients. Antiviral therapy was given to 33/37 (89%) patients, primarily oseltamivir (n = 24) and oseltamivir before or after another antiviral (n = 8). Excluding those with nosocomial A(H1N1)pdm09, 18/34 (52.9%) were hospitalized and 6 (33%) required admission to an intensive care unit. Mortality within 30 and 60 days of symptom onset was 7/37 (18.9%) and 11/37 (29.7%), respectively. Factors associated with mortality included nosocomial acquisition (P = 0.023), receipt of mycophenolate mofetil (P = 0.001), or antilymphocyte antibody (P = 0.005) within the past 6 months, reduced‐intensity conditioning (P = 0.027), and bacteremia (P = 0.021).ConclusionsA(H1N1)pdm09 infection was particularly severe in HSCT recipients, specifically among those receiving augmented immunosuppression for graft‐versus‐host disease. The high mortality of the nosocomial cases highlights the need for strict infection‐control measures in hospitals during influenza outbreaks.
Faculty Opinions recommendation of Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.
Wu, Long‐Jun , Eyo, Ukpong B , Eyo, Ukpong B.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | July 25, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718003795.793480355 Get It

Gordonia Bacteremia
Ramanan, Poornima , Deziel, Paul J. , Wengenack, Nancy L.

Journal of Clinical Microbiology | July 25, 2013 | Volume: 51 | Issue: 10 | Pages: 3443-3447

10.1128/jcm.01449-13 | PMID 23884999 Get It

ABSTRACT Gordonia species are ubiquitous aerobic actinomycetes that rarely cause infection in humans. We report the second known case of Gordonia otitidis catheter-related bacteremia in an immunocompromised patient and review four additional cases of Gordonia bacteremia seen at our institution over the past 14 years. In addition, the existing literature on Gordonia infections is reviewed.
Myocardial Stretch in Early Systole is a Key Determinant of the Synchrony of Left Ventricular Mechanical Activity in vivo
Caracciolo, Giuseppe, Goliasch, Georg , Amaki, Makoto , Bansal, Manish , Nakabo, Ayumi, Scott, Luis R. , Lipar, Luka, Pedrizzetti, Gianni , Sengupta, Partho P. , Abe, Haruhiko , Narula, Jagat

Circulation Journal | July 25, 2013 | Volume: 77 | Issue: 10 | Pages: 2526-2534

10.1253/circj.cj-12-1230 | PMID 23883873 Get It

Automatic Selection of Tube Potential for Radiation Dose Reduction in Vascular and Contrast-Enhanced Abdominopelvic CT
Yu, Lifeng , Grant, Katharine L., Carter, Rickey E. , Hough, David M., Barlow, John M. , Vrtiska, Terri J., Williamson, Eric E. , Young, Phillip M. , Goss, Brian C., Shiung, Maria, Raupach, Ranier, Schmidt, Bernhard , Flohr, Thomas , Yu, Lifeng , Fletcher, Joel G. , Leng, Shuai , McCollough, Cynthia H. , Carter, Rickey E

American Journal of Roentgenology | July 24, 2013 | Volume: 201 | Issue: 2 | Pages: W297-W306

10.2214/ajr.12.9610 | PMID 23883244 Get It

Impact of a drug utilization review program on high‐risk use of prescription controlled substances
Daubresse, Matthew, Gleason, Patrick P., Shah, Nilay D. , Ritter, Stephen T., Peng, Yi , Alexander, G. Caleb

Pharmacoepidemiology and Drug Safety | July 24, 2013 | Volume: 23 | Issue: 4 | Pages: 419-427

10.1002/pds.3487 | PMID 23881609 Get It

ABSTRACTBackgroundPrescription drug abuse has prompted considerable concern. We evaluated a retrospective drug utilization review program to reduce controlled substance use among individuals with high‐risk utilization.MethodsWe analyzed pharmacy claims from a large pharmaceutical benefits manager. For each eligible member, we calculated a controlled substance score based on the number and type of claims, prescribers and pharmacies, and utilization patterns over three months. Two state health plans sent controlled substance letters to prescribers of members meeting or exceeding a plan‐ and pre‐specified controlled substance score. Two different state health plans did not send such letters. We used a difference‐in‐difference design and generalized estimating equations to quantify the impact of the program on the mean difference in reduction of the controlled substance score over six months.ResultsEligible members in the intervention and comparison states had similar baseline mean controlled substance scores (19.0 vs. 18.6, p = 0.36). Adjusting for individuals' age, sex and pharmacy risk group score, reductions in the mean controlled substance score were greater in the intervention than comparison cohort (5.67 vs. 4.31, p = 0.01), corresponding with a 34.0% reduction in the intervention cohort compared to a 25.5% reduction in the comparison cohort. Changes were driven primarily by reductions in the number of controlled substance claims filled (30.5% vs. 23.1%, p = 0.01), as well as by a non‐statistically significant trend towards reductions in the number of prescribers and pharmacies used (26.9% vs. 20.1%, p = 0.07).ConclusionsRetrospective drug utilization review programs may reduce controlled substance scores and claims among individuals with patterns suggesting high‐risk utilization. Copyright © 2013 John Wiley & Sons, Ltd.
Standardizing Central Line Safety
Mueller, Jeff T., Wright, Alan J. , Fedraw, Leslie A., Murad, M. Hassan , Brown, Daniel R. , Thompson, Kristine M., Flick, Randall P., Seville, Maria Teresa , Huskins, W. Charles , Murad, M Hassan , Huskins, W Charles

American Journal of Medical Quality | July 24, 2013 | Volume: 29 | Issue: 3 | Pages: 191-199

10.1177/1062860613494752 | PMID 23880777 Get It

The Use of Open-Cell Foam and Elastic Foam Tape as an Affordable Skin Simulator for Teaching Suture Technique
Janus, Jeffrey R. , Hamilton, Grant

JAMA Facial Plastic Surgery | July 24, 2013 | Volume: 15 | Issue: 5 | Pages: 385-387

10.1001/jamafacial.2013.137 | PMID 23846432 Get It